You are here
September 11, 2013
Loyola prescribing ovarian cancer vaccine in clinical trial
Dr. Patrick Stiff, director of Loyola's Cardinal Bernardin Cancer Center, discusses how ovarian cancer is seen as a "silent" disease and is often not detected until an advanced stage. One Loyola patient, Colleen Olund, talks about how she entered this clinical trial and what it meant for her.
The goal of a cancer vaccine is to re-educate the immune system to recognize and fight off cancer cells. This type of clinical trial is offered at only a few academic medical centers. Mrs. Olund has done so well and she hopes that others will take part. They have a better chance of recovering and would be adding to the body of research in the battle against ovarian cancer.
To learn more about clinical trials for cancer at Loyola, please call (708) 216-5994.